ACASTI PHARMA INC - NASDAQ: $ACST Picking Its Head UpSince breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above.
With the stock trading above all of its important moving averages 20/50/200 DMA's, the technical picture remains favorable despite the lack of upside progress over the past 8-9 months.
While ACST requires further work, both investors/traders may want to continue to monitor the action closely in the days/weeks ahead. In particular, should ACST be capable of clearing the $1.15 hurdle, such development may just ignite the stock and finally break free from its long slumber.
Thus, both investors/traders may want to put ACST front-and-center on their radars.
Healthcare
ENZO BIOCHEM INC - NYSE: $ENZ FlaggingLast week, ENZO BIOCHEM INC - NYSE:ENZ broke to higher ground and in the process, recaptured its 200 DMA out of a rounding bottom and now finds itself digesting/consolidating the move within a Flag pattern on lower volume as is evidenced in the Daily chart above.
In addition, ENZ is now trading above all of its important moving averages 20/50/200 DMA's and finds itself in fine technical shape.
Moving forward, both investors/traders may want to continue to monitor the action with a close eye. Specifically, should ENZ be capable of going topside of the $4.50 figure, such development would likely trigger its next advance with a primary objective in the $5-$6 zone with a secondary potential objective at $7 further down the road.
Nevertheless, investors/traders may want to put ENZ front-and-center on their radars.
Omnicell testing supportOmnicell is testing support this afternoon around the $81.50-$81.70. This has been a fairly high-volume level this week, so it should provide fairly solid support.
Without catalysts in either direction, Omnicell may trade for a while in a range between the $81.50-$81.70 support level and $83.70-$84.00 resistance level. The healthcare sector as a whole appears range-bound at the moment.
A downturn in technology stocks on tariff fears could be good for domestic healthcare stocks as a defensive play. Watch for that possibility next week.
Omnicell bottom triangle patternOmnicell is trying for the second time in recent history to make a bullish bottom triangle chart pattern. Most analysts are bullish on the stock, and it's spent most of its recent trading history on the upper side of the triangle. This morning the stock was repulsed by resistance at its May 6 close of 83.79. However, it may try again. Look for a close above that level to confirm the trend.
FLEX PHARMA INC - NASDAQ: $FLKS Ready To Rumble?For the past year, FLEX PHARMA INC - NASDAQ:FLKS has found itself in base mode with the exception of a handful of sharp violent upside moves accompanied with large volume as is evidenced in the Daily chart above.
In addition, we can observe that FLKS presently finds itself trading above all of its important moving averages 20/50/200 DMA's, which is technically healthy.
We are watching the action very closely here as we suspect that we may very well be nearing another potential explosive move that should such development occur, we would not be the least bit surprised if the stock were to power-up into the $0.75-$1 zone in rapid fashion.
Thus, both investors/traders may want to put FLKS front-and-center on their radars with a close eye on any volume pick-up that may provide clues that the stock is ready for another potential burst into northern ground.
ZIOPHARM ONCOLOGY INC. - NASDAQ: $ZIOP Building BaseAfter recapturing its 200 DMA back in March and subsequently vaulting from a 3 to 4 - handle, ZIOPHARM ONCOLOGY INC - NASDAQ:ZIOP has found itself in a sideways drift and appears to be building a base these past couple of months as we can observe from the Daily chart above.
With the stock trading above all of its important moving averages 20/50/200 DMA's, ZIOP remains in a favorable technical posture as the base building process continues to develop.
In addition, if one were to zoom-out to both the Weekly and Monthly time-frames, we can also see that ZIOP may just be in the process of building-out a potential inverted H&S pattern and should such development materialize and complete, the longer-term measured move implies an initial $8 objective.
Moving forward, if and when at any time in the days/weeks ahead ZIOP is capable of clearing the $4.85 figure and perhaps more importantly the $5 level, such occurrence would likely suggest that higher levels are in the offing.
Thus, both investors/traders may want to continue to monitor the action closely moving forward.
R1 RCM INC - NASDAQ: $RCM Blue Sky's Await?After breaking to higher ground last month, shares of R1 RCM INC - NASDAQ:RCM have been digesting/consolidating the move in orderly fashion and now finds itself pressing the upper level and nearing a potential break for all-time highs as well as Blue Sky's as evidenced in the Daily chart above.
In addition, RCM presently trades above all of its important moving averages 20/50/200 DMA's, which portrays a healthy technical picture and posture. Furthermore, the stock has been putting-in higher lows; higher highs throughout the 2019 calendar validating its uptrend.
Moving forward, should RCM be capable of going topside of the 12.50 figure and can hold and or sustain, it's all-time high and Blue Sky territory.
Thus, both investors/traders may want to continue to monitor the action closely in the days ahead for signs/clues that RCM has loftier levels in sight.
AMARIN CORP - NASDAQ: $AMRN Setting-UpAfter breaking to higher ground in 1Q19 and subsequently drifting back down to its original break-out level in the upper teen's, the shares of AMARIN CORP NASDAQ: AMRN are once again starting to show signs of potentially setting-up for another attempt at loftier levels as evidenced in the Daily chart above.
While AMRN presently finds itself in drift mode working on its right-side, the stock continues to display favorable technical characteristics trading above all of its important moving averages (20/50/200 DMA's).
Although further work is required, it appears that we may just witness a repeat of 1Q whereby buyers once again start to take control of the stock and should such scenario materialize, we suspect that it may have eyes for the $22 - $24 zone once again in the short-term.
Thus, both investors/traders may want to continue to monitor the action closely in the days/weeks ahead for signs/clues that a move for greener pastures is underway.
BIOMARIN - GOOD BUY OPPORTUNITYToday we gonna look at the pharmaceutical company, as a potential new giant trend on the stock market. NASDAQ:BMRN laying on the strong support line near $87.87 and can move up suddenly. My recommendation:
1. Buy now around 87.87
2. Take profit: 109.45
3. SL: 78.68
Risk/Reward - 2.39, potential profit - 24,6%
$JSENTC Netcare 911, we have an emergency!This chart looks like an emergency that requires an urgent intervention! Perhaps the major volume seen today could be an indication of capitulation and i will be monitoring the price action in the days ahead to see if it is able to recover from these over extended levels. Should this level hold which is also coincidentally the bottom of the downward sloping channel, we could see a bounce take place to the R21.00 - R21.60 area. R21.60 is an area where the chart also has a small gap which might want to fill first before any further downside ensues.
Long GWPHUrg.. tradingview decided to hide a lot of my previous idea because I didn't go pro, what a scam.
If you like my charts and would like to support me going pro for $12.95, please msg me so i can keep sending out these ideas weekly.
TradingView
Open position at $182
Stop loss at $180
Take profit at $187
Why this play?
Gwph had a pretty good earning but got beaten down due to market conditions.
they had a lot of upgrades with price range of $200+ the last few days but they can't move with market uncertainty.
AS soon as market runs, they will fly, but ofc that will depend on market.
XLV recovering for SummerXLV pulled back sharply largely to do with a knee-jerk reaction to the Dems ‘Medicare for all’ (ie Europe-style government health service). Contrast this to the general Dec 2018 market collapse, and we see
- a 7.2% W1 rise
- a 50% W2 pullback
- a W3 repeating the move, and running to the 1.618 fib
The price carried on after December, but just anticipating a repeat of that move gives us an entry at 87.75 for 94.00. A 1.4% stop is comfortable (86.50) to give a 5:1 trade.
Healthcare is a typically strong summer defensive, and notably (on the daily chart), after the outlier of Dec 2018, kept in its long-term channel in the April collapse.
Short the Red box :OWe have a good shorting Opp here. Its showing signs of reversal on most timeframes especially the larger ones such at the Month, Week and Daily.
Noone can see 3-4 years into the future right? Well I'm no different so dont take this as financial advice more of just a hey this looks ok to me sort of thing. Ive taken the time to give you a Fan, a Triangle, and major resistance and support levels on larger time frames. Take the time do your own research but hope this helps guide some in the right direction Enjoy :)
Purple is Monthy
Yellow is weekly
White is Heavy resistance/support lines due to large moves up/down
Red Box: Short Area
Overall Target it is 18-19, with potential to break through to 7-8
Long ABT on Breakout!Order set to buy ABT above the high of the current base. Good form with good contractions and declining volume.
Short term up, long term trend brokenHealth care being hit hard due to politics, won't affect earnings this year but puts a cloud in the air. Expect short term bounce into earnings
Marker Therapeutics seems bullishMMHVW - do your own research - the share price has remained above the 49dma for the first time in a bullish manner. This could be signaling change in trend. I’m holding for time being.
Biogen Inc: Rare Long-Term Buy Opportunity.Biogen has lost over 30% of its value this month. Looking at the monthly chart, we have concluded that this is a rare investment opportunity as the current price is just above its 1M Support Zone.
Historically we see that such an aggressive sell off recently took place in 2015 - 2016 and again the stock managed to recover almost reaching the 390 Resistance again. This pattern may be similar to the one the long term (~10 year) consolidation that took place after the 2000 peak. The price then traded sideways roughly within 17.00 - 71.00, providing a buy opportunity on every major pull back.
We believe such an opportunity is presented now. Every dip near the 180 - 205 Support Zone can be bought with 350 - 390 as the Target Zone.
** If you like our free content follow our profile (www.tradingview.com) to get more daily ideas. **
Comments and likes are greatly appreciated.
Biib - Good Pe & strong market- Bottom fishing?Take position 223.05
Stoploss at after 222,
Take profit 228
if that breaks, switch to short and ride it to to 205.
But PE is really low for a bio stock,fundamentally, it's good value.
If we get a rally again in the market and sector(LABU) continue to push. this will probably go sideways.
Innovate Biopharmaceuticals 3.55 target on good reportinglot of lines and PTs can elevate fast if this breaks out on volume inflation in April
Notice the 1M candle is Red 9 for March. Ideal play here is an entry under $2.00 (on support retest)
if we change cycle from accumulation to Bull Cycle, look for late 2019 take profit area (Sept-Dec)
